e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Genetics and genomics of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetic differences in COPD secondary to wood smoke and tobacco smoking
G. Pérez-Rubio, R. Falfán-Valencia, A. Ramírez-Venegas, J. C. Fernández-López, A. Camarena, M. I. Vargas, R. Sansores (México, Mexico)
Source:
Annual Congress 2013 –Genetics and genomics of lung disease
Session:
Genetics and genomics of lung disease
Session type:
Thematic Poster Session
Number:
1401
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Pérez-Rubio, R. Falfán-Valencia, A. Ramírez-Venegas, J. C. Fernández-López, A. Camarena, M. I. Vargas, R. Sansores (México, Mexico). Genetic differences in COPD secondary to wood smoke and tobacco smoking. Eur Respir J 2013; 42: Suppl. 57, 1401
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Influence of gene-by-early environmental tobacco smoke exposure interactions on time-to-asthma onset
Source: International Congress 2016 – Predictors of asthma among children and adults
Year: 2016
Genetic-environmental interactions in COPD – not only smoke?
Source: Annual Congress 2005 - PG13 - COPD: genetic and environmental factors, epidemiology, socio-economic impact and preventative measures
Year: 2005
COPD in Chinese nonsmokers
Source: Eur Respir J 2009; 33: 509-518
Year: 2009
Environmental tobacco smoke and health in the elderly
Source: Eur Respir J 2002; 19: 172-181
Year: 2002
Passive and active smoking in childhood for COPD
Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence
Year: 2005
Relationship between the influence of exposure to tobacco smoke and max-IMT, ABI, ratio of EPA / AA in COPD patients
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
Influence of tobacco smoking on adhesion molecules profiles in patients with chronic obstructive lung disease
Source: International Congress 2014 – Passive smoking, active smoking and COPD
Year: 2014
Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Oral and nasal microbiota in healthy, tobacco smoke COPD (TSCOPD) and biomass smoke COPD (BMSCOPD) subjects from India
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
TNF promoter polymorphisms are associated with susceptibility and increased severity in secondary to tobacco and biomass smoke COPD in Mexican population
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Lung function of school children with low levels of α1-antitrypsin and tobacco smoke exposure
Source: Eur Respir J 2002; 19: 1099-1106
Year: 2002
Clinico-radiological and functional assessment of respiratory symptomatics with either exposure to biomass fuel smoke or tobacco smoking
Source: International Congress 2016 – The indoor and ambient environments
Year: 2016
Workplace smoking restriction and respiratory health: the Irish experience
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Occupational COPD and tobacco smoking
Source: Eur Respir J 2005; 26: Suppl. 49, 149s
Year: 2005
Long term effects of environmental tobacco smoke in the European Community Respiratory Health Survey II
Source: Annual Congress 2006 - Highlights of asthma epidemiology
Year: 2006
Beyond personal smoking: does environmental tobacco smoke cause chronic obstructive pulmonary disease?
Source: Annual Congress 2005 - Environmental tobacco smoke and obstructive lung disease
Year: 2005
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
The evaluation of the role of smoking and environmental tobacco smoke exposure on asthma bronchiale by Asthma Control TestÔ
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008
Lung function differences between subjects with tobacco smoke-induced COPD (TS-COPD) and biomass smoke-induced COPD (BS-COPD) in an Indian population
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
Nicotine dependence and changes in smoking status among smokers - report from the obstructive lung disease in Northern Sweden COPD study
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept